Is anyone currently enrolled in this trial? My doctor mentioned this as maybe an option besides V&O. I looked at it but apparently there are several phases, this is the one we are looking at:
BRUIN CLL-322: a Phase 3 open-label, randomized study of fixed duration pirtobrutinib (LOXO-305) plus venetoclax and rituximab versus venetoclax and rituximab in previously treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Any feedback is appreciated.
Members Osprey69, steve5441 and UKfulloflife joined a LOXO-305 trial.
Neil
I am currently in Loxo trial- as single agent. Started trial in 6/19 with very few side effects. I am now starting to show alittle resistance but will continue with trial until my numbers indicate I have to make a change. Bruin CLL trial with that combination looks good. Best of luck with your decision. Fran
FDA Frontline Approval of Venetoclax and Obinituzumab in the USA
Anyone thinking to postpone rituximab doses until Omicron wave is over?I am new here and about to start venetoclax/rituximab treatment.Dr. John Allan - Chronic Lymphocytic Leukemia (CLL) Patients @Undetectable Measurable Residual Disease (MRD) after Ibrutinib Plus VenetoclaxEnd of suspense! Here is Dr. Koffman's ASCO 2020 "Top Pick" #1!
